Physician
Healtheast ST. John's Hospital
Healtheast ST. John's Hospital was paid $17.91M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99285, emergency room visit (most serious) — 40% of everything it billed.
33Billing provider infoHEALTHEAST ST. JOHN'S HOSPITAL
MAPLEWOOD, MN 55109
MAPLEWOOD, MN 55109
33aNPI1447218482assigned 05/01/2006
33bProvider typeEmergency Medical Services (Emergency Medicine) Physician
28Total paid$17.91M
24GClaims241,569
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,418 | $1.43M | |
| 2019 | 40,379 | $2.75M | |
| 2020 | 21,752 | $1.59M | |
| 2021 | 24,494 | $1.88M | |
| 2022 | 33,614 | $3.13M | |
| 2023 | 44,693 | $4.09M | |
| 2024incomplete | 30,219 | $3.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 40% | 20,825 | 19,265 | $7.23M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 14,824 | 13,826 | $3.36M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.7% | 8,678 | 8,252 | $1.56M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.9% | 16,327 | 14,562 | $1.05M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.6% | 8,876 | 8,079 | $1.01M |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 23,617 | 20,728 | $424K |
| H2035 | Alcohol and/or other drug treatment program, per hour | 2.3% | 3,409 | 560 | $403K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.2% | 1,873 | 1,467 | $398K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 4,590 | 4,017 | $393K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.5% | 2,643 | 2,229 | $270K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.4% | 2,839 | 1,497 | $250K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 1,761 | 1,724 | $234K |
90 more codes
| 80053 | Comprehensive metabolic panel | 1.2% | 15,113 | $212K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,950 | $131K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,826 | $112K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,321 | $90K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 311 | $73K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 419 | $69K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,043 | $65K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 792 | $49K |
| 93798 | <1% | 581 | $49K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 373 | $44K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 238 | $44K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 12,375 | $37K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,194 | $34K |
| G0378 | Hospital observation service, per hour | <1% | 207 | $32K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 545 | $25K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 234 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,705 | $21K |
| 76820 | <1% | 321 | $18K | |
| A9270 | Non-covered item or service | <1% | 1,923 | $15K |
| 76801 | <1% | 130 | $15K | |
| 59025 | Fetal non-stress test | <1% | 86 | $14K |
| 90837 | Psychotherapy session, about an hour | <1% | 283 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 214 | $11K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 638 | $10K |
| 11043 | <1% | 16 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 213 | $9K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 105 | $8K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 180 | $8K |
| 85027 | <1% | 10,399 | $7K | |
| 84484 | <1% | 3,607 | $6K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,138 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 38 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 59 | $5K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 52 | $5K |
| 81001 | <1% | 6,437 | $4K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 87 | $4K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 40 | $4K |
| 97597 | <1% | 123 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,075 | $3K |
| J3490 | Unclassified drugs | <1% | 1,404 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,090 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 290 | $2K |
| 83690 | <1% | 3,350 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 106 | $2K |
| 82962 | <1% | 392 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 31 | $2K |
| 83735 | <1% | 2,143 | $2K | |
| 82248 | <1% | 3,099 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $2K |
| 73630 | <1% | 14 | $1K | |
| 20552 | <1% | 13 | $978.33 | |
| 83880 | <1% | 15 | $686.71 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 309 | $435.70 |
| 85610 | <1% | 338 | $429.50 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 769 | $426.52 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,526 | $395.80 |
| 96040 | <1% | 14 | $315.15 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $289.66 |
| 81003 | <1% | 370 | $267.90 | |
| 81025 | <1% | 671 | $267.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,457 | $189.47 |
| 82607 | <1% | 14 | $181.51 | |
| 87650 | <1% | 403 | $177.40 | |
| 85379 | <1% | 48 | $164.87 | |
| 83605 | <1% | 60 | $123.41 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 77 | $95.23 |
| 86140 | <1% | 82 | $93.18 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 12 | $86.09 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 117 | $74.36 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 706 | $61.66 |
| 82570 | <1% | 14 | $54.10 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 322 | $52.53 |
| 85730 | <1% | 25 | $28.14 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 26 | $24.60 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 70 | $22.59 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $21.13 |
| J2704 | Injection, propofol, 10 mg | <1% | 15 | $16.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 120 | $15.52 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 13 | $13.75 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 32 | $13.42 |
| 84703 | <1% | 29 | $7.66 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 60 | $5.90 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 17 | $2.45 |
| 84702 | 0% | 12 | $0.00 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 0% | 104 | $0.00 |
| 87210 | 0% | 12 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 39 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 20 | $0.00 |
| 87807 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
| Fairview Clinics | Princeton, MN | $4.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.